Figure 7
From: Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
Interferon γ production by spleen cells of FVB-huHER2-vaccinated mice. Mean ± SEM data are shown for each group (n = 3 to 6 mice per group). Spleen cells were cultured alone (spont) or in the presence of huHER2-positive cancer cells of syngeneic (syn-HER2) or xenogeneic (xeno-HER2) origin. *P ≤ 0.05 vs. other groups. HuRT, chimeric human/rat HER2 plasmid electroporated vaccine; IFN, interferon.